Research carried out in part by an artificially-intelligent (AI) ‘robot scientist’ has found that a common ingredient of toothpaste could be developed to fight drug-resistant strains of malaria. Scarlett Cvitanovich reports. Continue reading
RACINE, Wis., Aug. 3, 2016 /PRNewswire/ — During “mosquito season,” which in the continental U.S. lasts typically from late spring to early fall, when mosquito activity is highest, it may seem like mosquitoes are drawn to some people more than to others. Speculations about the potential causes of this “mosquito affinity” range from differences in blood types, hormones, skin care products or diets we follow.
Britain will spend 500 million pounds (700 million US dollars) per year for the next five years to battle malaria in a partnership with Microsoft founder and philanthropist Bill Gates worth a total of 3 billion pounds (4 billion US dollars).
Biomedical engineers are developing a device that transforms a smartphone into an instrument that can quickly and accurately diagnose malaria in the field. Ben Gruber has more.
China Central Television (CCTV)- Health Officials from African countries on Tuesday hailed Chinese drug Artemisinin in playing a key role in combating the deadly malaria disease as they attended the 2nd Ministerial Forum on Africa-China Health Development in South Africa.
Groundbreaking work by the University of Cape Town Drug Discovery and Development Centre, in the research and development of a potential single-dose cure for malaria, has attracted international interest, funding and scientists from around the world. The compound is said to disrupt the malaria parasite’s life cycle in animal models, effectively destroying it. Researchers say they are optimistic the drug will be effective in fighting malaria in future.